14 Surgical excision is the first-line treatment for SCC and is indicated for all invasive SCC
Liu YC, Shen CL, Fu ZY, Zhang YC, Han YX, Chen BJ, et al
Semaglutide, as well as other GLP-1 receptor agonists, has been shown to improve glycemic homeostasis in T2D mouse models and to restore the expression of key -cell transcription factors [31, 32]
The Science Supporting Our Approach Our protocols are directly informed by the latest clinical research, including the groundbreaking 2025 Galderma study that specifically examined facial volume loss in patients using GLP-1 medications
outcomes vary by medication, duration, and individual factors
The metabolic adaptations that contributed to weight lossincluding reduced hunger signalling and delayed gastric emptyingdiminish as the medication clears from the system